Company Search:
Advanced Search
Sponsored Links
Eyegate Pharmaceuticals Inc Company Snapshot
Eyegate Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eyegate Pharmaceuticals Inc with three other companies in this sector in the United States: Cardax Inc (2018 sales of $1.51 million ), Adverum Biotechnologies Inc ($1.61 million of which 100% was Developing and Commercializing Therapeut), and Bioxyne Limited ($1.54 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eyegate Pharmaceuticals Inc
  Stock Performance Chart for Eyegate Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 4.69
(Figures in U.S. Dollars)
1 Week 15.9%   13 Weeks 39.6%  
4 Weeks 59.1%   52 Weeks -34.8%  
Eyegate Pharmaceuticals Inc Key Data:
  Ticker: EYEG Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 1,652,520
(Year Ending Jan 2019).
Employees: 11
  Currency: U.S. Dollars Market Cap: 14,280,977
  Fiscal Yr Ends: December Shares Outstanding: 3,045,049
  Share Type: Common Closely Held Shares: 470,802
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.